No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skincare needs. Within its medical beauty offerings, Imeik provides a range of recognized brands including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. Additionally, its comprehensive skincare line features hydrating lotions, anti-aging and firming serums, concentrated essence creams, revitalizing facial masks, restorative chitosan B5 sprays, and clarifying and illuminating liquids. Established in 2004, the company's operations are based in Beijing, China.
www.imeik.comNo one on the platform currently holds 300896.SZ.
No tracked institution reports a position in 300896.SZ as of their last filing.
No one on the platform has traded 300896.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 17.8% | — | — | — | ||
| Rev. Growth % | -19.9% | 27.9% | ||||
| Profit Margin % | 53.3% | 62.8% | 54.4% | |||
| Free Cash Flow Margin % | 50.2% | |||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2.6B | +1.2% | $4.16 | $3.96–$4.36 | — | 6 |
| 2027 | $2.8B | +9.6% | $4.60 | $4.26–$5.21 | — | 8 |
| 2028 | $3.1B | +11.7% | $5.19 | $4.14–$6.21 | — | 10 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-20 | $1.27 | $0.97 | -23.9% |
| 2026-04-22 | $0.99 | $0.99 | -0.2% |
| 2026-03-20 | $0.94 | $0.65 | -30.5% |
| 2025-10-28 | $1.01 | $1.01 | +0.0% |
| 2025-08-18 | $1.15 | $1.14 | -0.9% |
| 2025-04-24 | $1.74 | $1.47 | -15.5% |
| 2025-03-20 | $1.22 | $1.36 | +11.5% |
| 2024-10-23 | $1.90 | $1.54 | -18.9% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300896.SZImeik Technology Development Co.,Ltd. | $88.34 | -0.11% | $26.7B | — |
| 000999.SZChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | $24.12 | -0.74% | $40.1B | — |
| 002223.SZJiangsu Yuyue Medical Equipment & Supply Co., Ltd. | $26.07 | +2.24% | $26.1B | — |
| 002252.SZShanghai RAAS Blood Products Co., Ltd. | $4.91 | -0.81% | $32.4B | — |
| 300347.SZHangzhou Tigermed Consulting Co., Ltd |
| $55.81 |
| -1.05% |
| $41.2B |
| — |
| 300759.SZPharmaron Beijing Co., Ltd. | $42.36 | -0.68% | $62.6B | — |
| 300832.SZShenzhen New Industries Biomedical Engineering Co., Ltd. | $48.95 | +0.84% | $38.5B | — |
Source: Financial Modeling Prep · peers by sector/industry